Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Maryland’s policymakers should expand Medicaid coverage to include weight loss medications, writes Michelle Rogers.

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

A Lancet study suggests that popular weight-loss drugs could lead to muscle loss. Researchers recommend combining these ...

When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.GLP-1 ...

Novo Nordisk's involve the GLP-1 pathway, while Eli Lilly's treatments activate both ... You'll probably recognize their ...